Year |
Citation |
Score |
2015 |
Duke AN, Johnson MW, Reissig CJ, Griffiths RR. Nicotine reinforcement in never-smokers. Psychopharmacology. PMID 26345343 DOI: 10.1007/S00213-015-4053-4 |
0.503 |
|
2015 |
Reissig CJ, Harrison JA, Carter LP, Griffiths RR. Inhaled vs. oral alprazolam: subjective, behavioral and cognitive effects, and modestly increased abuse potential. Psychopharmacology. 232: 871-83. PMID 25199955 DOI: 10.1007/S00213-014-3721-0 |
0.666 |
|
2013 |
MacLean KA, Johnson MW, Reissig CJ, Prisinzano TE, Griffiths RR. Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects. Psychopharmacology. 226: 381-92. PMID 23135605 DOI: 10.1007/S00213-012-2912-9 |
0.772 |
|
2013 |
Carter LP, Reissig CJ, Johnson MW, Klinedinst MA, Griffiths RR, Mintzer MZ. Acute cognitive effects of high doses of dextromethorphan relative to triazolam in humans. Drug and Alcohol Dependence. 128: 206-13. PMID 22989498 DOI: 10.1016/J.Drugalcdep.2012.08.025 |
0.765 |
|
2013 |
Carter LP, Reissig CJ, Johnson MW, Klinedinst MA, Griffiths RR, Mintzer MZ. Corrigendum to Acute cognitive effects of high doses of dextromethorphan relative to triazolam in humans [Drug Alcohol Depend. 128 (2013) 206-213] Drug and Alcohol Dependence. 133: 294. DOI: 10.1016/J.Drugalcdep.2013.06.006 |
0.73 |
|
2013 |
Reissig CJ, Carter LP, Johnson MW, Mintzer MZ, Klinedinst MA, Griffiths RR. Erratum to: High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens Psychopharmacology. 228: 513-513. DOI: 10.1007/S00213-013-3172-Z |
0.76 |
|
2012 |
Reissig CJ, Carter LP, Johnson MW, Mintzer MZ, Klinedinst MA, Griffiths RR. High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens. Psychopharmacology. 223: 1-15. PMID 22526529 DOI: 10.1007/S00213-012-2680-6 |
0.781 |
|
2011 |
Johnson MW, MacLean KA, Reissig CJ, Prisinzano TE, Griffiths RR. Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum. Drug and Alcohol Dependence. 115: 150-5. PMID 21131142 DOI: 10.1016/J.Drugalcdep.2010.11.005 |
0.776 |
|
2009 |
Reissig CJ, Strain EC, Griffiths RR. Caffeinated energy drinks--a growing problem. Drug and Alcohol Dependence. 99: 1-10. PMID 18809264 DOI: 10.1016/J.Drugalcdep.2008.08.001 |
0.476 |
|
2008 |
Reissig CJ, Rabin RA, Winter JC, Dlugos CA. d-LSD-induced c-Fos expression occurs in a population of oligodendrocytes in rat prefrontal cortex. European Journal of Pharmacology. 583: 40-7. PMID 18262520 DOI: 10.1016/J.Ejphar.2007.12.031 |
0.538 |
|
2008 |
Fantegrossi WE, Murnane KS, Reissig CJ. The behavioral pharmacology of hallucinogens. Biochemical Pharmacology. 75: 17-33. PMID 17977517 DOI: 10.1016/J.Bcp.2007.07.018 |
0.391 |
|
2008 |
Reissig CJ, Eckler JR, Rabin RA, Rice KC, Winter JC. The stimulus effects of 8-OH-DPAT: evidence for a 5-HT2A receptor-mediated component. Pharmacology, Biochemistry, and Behavior. 88: 312-7. PMID 17936346 DOI: 10.1016/J.Pbb.2007.09.011 |
0.756 |
|
2008 |
Fantegrossi WE, Reissig CJ, Katz EB, Yarosh HL, Rice KC, Winter JC. Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): Possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents Pharmacology Biochemistry and Behavior. 88: 358-365. PMID 17905422 DOI: 10.1016/J.Pbb.2007.09.007 |
0.676 |
|
2008 |
Griffiths RR, Reissig CJ, First MB. Substance Abuse: Caffeine Use Disorders Psychiatry: Third Edition. 1: 1019-1040. DOI: 10.1002/9780470515167.ch56 |
0.331 |
|
2005 |
Reissig CJ, Eckler JR, Rabin RA, Winter JC. The 5-HT1A receptor and the stimulus effects of LSD in the rat. Psychopharmacology. 182: 197-204. PMID 16025319 DOI: 10.1007/S00213-005-0068-6 |
0.758 |
|
2005 |
Winter JC, Kieres AK, Zimmerman MD, Reissig CJ, Eckler JR, Ullrich T, Rice KC, Rabin RA, Richards JB. The stimulus properties of LSD in C57BL/6 mice. Pharmacology, Biochemistry, and Behavior. 81: 830-7. PMID 16005500 DOI: 10.1016/J.Pbb.2005.05.014 |
0.751 |
|
2004 |
Eckler JR, Reissig CJ, Rabin RA, Winter JC. A 5-HT(2C) receptor-mediated interaction between 2,5-dimethoxy-4-methylamphetamine and citalopram in the rat. Pharmacology, Biochemistry, and Behavior. 79: 25-30. PMID 15388280 DOI: 10.1016/J.Pbb.2004.06.012 |
0.733 |
|
Show low-probability matches. |